Compound Profile
Graviola Annona Muricata
Graviola is safety concerning due to annonaceous acetogenins and neurotoxicity signals; no clinical efficacy evidence supports therapeutic use.
Last reviewed:
C PreliminaryMonograph visual
Graviola Annona Muricata
Generated profile category visual
Where to go next — guides & comparisons
Continue reading
- If you want to browse more compounds → All compounds
Quick Stats
Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Standard caution: Generally well tolerated
Best for
Mitochondrial Function, Neuronal Toxicity Pathways
Safety & Cautions
Neurotoxicity/Parkinsonism like concerns; mitochondrial toxicity; no established safe therapeutic dose.
Evidence Summary
C PreliminaryEvidence lens
Early signal that needs stronger human replication before practical claims.
PreliminaryLimited evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Cytotoxicity Induction · Neuroprotective Activity · Mitochondrial Support
Research maturity: Preliminary or mixed — main contexts: Mitochondrial Function · Neuronal Toxicity Pathways
Safety boundary: Safety note available — Neurotoxicity/Parkinsonism like concerns; mitochondrial toxicity; no established safe therapeutic dose.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Graviola Annona Muricata has a limited evidence evidence rating.
AdaptogenStress & MoodLongevity
Effects
2
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
A
Strong
Multiple RCTs, consistent direction, adequate effect size
B
Moderate
Some RCTs or consistent observational data in humans
C
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
D
Traditional / Theoretical
Traditional use only; no controlled human trials
How Graviola Annona Muricata Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Graviola Annona Muricata Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways▼
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Cytotoxicity InductionNeuroprotective ActivityMitochondrial SupportOxidative Stress ModulationMitochondrial Complex I Inhibition
Condition guides
Continue exploring
Related research paths
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Graviola Annona Muricata
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Graviola Annona Muricata evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Compound profile context
How to interpret Graviola Annona Muricata
Graviola dosage by use case, onset and duration, safety limits, and interactions for mitochondrial function, graded against research. Limited Human Evidence… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Graviola Annona Muricata, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.